Vitamin D Metabolism in Chronic Renal Disease

  • Jacob LemannJr.
  • Richard W. Gray
  • Nancy D. Adams


This chapter provides a summary of current knowledge of vitamin D metabolism and abnormalities of vitamin D nutrition and metabolism among patients with chronic kidney disease.


Chronic Renal Failure Dialysis Patient Chronic Renal Disease Dietary Calcium Intake Renal Osteodystrophy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Holick MF, Richtand NM, McNeill SC, Holick SA, Frommer JE, Henley JW, Potts JT Jr: Isolation and identification of previtamin D3 from the skin of rats exposed to ultraviolet irradiation. Biochemistry 18:1003, 1979.PubMedCrossRefGoogle Scholar
  2. 2.
    Paul AA, Southgate DAT: McCance and Widdowson’s The Composition of Foods, 4th ed. Elsevier/North-Holland Biomedical Press, 1978.Google Scholar
  3. 3.
    DeLuca HF: Recent advances in our understanding of the vitamin D endocrine system, J Lab Clin Med 87:7, 1976.Google Scholar
  4. 4.
    Tucker G III; Gagnon RE, Haussler MR: Vitamin D3-25 hydroxylase: Tissue occurrence and apparent lack of regulation. Arch Biochem Biophys 155:47, 1973.PubMedCrossRefGoogle Scholar
  5. 5.
    Arnaud SN, Goldsmith RS, Lambert, PW, Go VLW: 25-Hydroxy-vitamin D3: Evidence of an enterohepatic circulation in man. Proc Soc Exp Biol Med 149:570, 1975.PubMedGoogle Scholar
  6. 6.
    Stamp TCB, Haddad JG, Twigg CA: Comparison of oral 25-hydroxycholecalciferol, vitamin D and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet 1:1341, 1977.PubMedCrossRefGoogle Scholar
  7. 7.
    Hughes MR, Baylink DJ, Jones PG, Haussler, MR: Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1α,25-dihydroxy-vitamin D2/D3. Applications to hypervitaminosis D. J Clin Invest 58:61, 1976.PubMedCrossRefGoogle Scholar
  8. 8.
    Haussler MR, McCain TA: Vitamin D metabolism and action. N Engl J Med 297:974, 1041, 1977PubMedCrossRefGoogle Scholar
  9. 9.
    Bordier P., Rasmussen H., Marie P., Miravet L., Gueris J, Ryckwaert, A: Vitamin D metabolism and bone mineralization in man. J Clin Endocrinol Metab 46:284, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    Queille ML, Miravet L, Bordier P, Redel J: The action of vitamin D metabolites [25-OH-D3, 1,25-(OH)2-D3, 24,25-(OH)2-D3, 25,26-(OH)2-D3] on vitamin D deficient rats. Biomedicine 28:237, 1978.PubMedGoogle Scholar
  11. 11.
    Tanaka Y., Halloran B, Schnoes HK, DeLuca HF: In vitro production of 1,25-dihydroxy-vitamin D3 by rat placental tissue. Proc Natl Acad Sci USA 76:5033, 1979.PubMedCrossRefGoogle Scholar
  12. 12.
    Bilezikian JP, Canfield RE, Jacobs TP, Polay JS, D’Adamo AP, Eisman JA, DeLuca HF: Response of 1α,25-dihydroxyvitamin D3 to hypocalcemia in human subjects. N Eng J Med 299:437, 1978.CrossRefGoogle Scholar
  13. 13.
    Adams ND, Gray RW, Lemann J Jr: The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults, J Clin Endocrinol Metab 48:1008, 1979.PubMedCrossRefGoogle Scholar
  14. 14.
    Trechsel U, Bonjour J-P, Fleish, H: Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells. J Clin Invest 64:206, 1979.PubMedCrossRefGoogle Scholar
  15. 15.
    Hughes MR, Brumbaugh PF, Haussler MR, Wergedal JE, Baylink DT. Regulation of serum 1α,25-dihydroxyvitamin D3 by calcium and phosphate in the rat. Science 190:578, 1975.PubMedCrossRefGoogle Scholar
  16. 16.
    Gray RW, Wilz DR, Caldas AE, Lemann J Jr: The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: Studies in healthy subjects, in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 45:299, 1977.PubMedCrossRefGoogle Scholar
  17. 17.
    Trechsel U, Eisman JA, Bonjour J-P, Fleish, H: Evidence for a calcium-dependent, PTH-independent regulation of plasma 1,25-dihydroxy-vitamin D in rats, in Norman AW, Schaefer K, von Herrath D, Grigoleit H-G, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds): Vitamin D. Basic Research and Its Clinical Application. Proc. IVth Vitamin D Workshop, Berlin, Walter deGruyter, 1979, p 511.Google Scholar
  18. 18.
    Holick MF, Schnoes HK, DeLuca HF, Gray RW, Boyle I, Suda, T: Isolation and Identification of 24,25-dihydroxycholecalciferol, a metabolite of vitamin D3 made in the kidney. Biochemistry 11:4251, 1972.PubMedCrossRefGoogle Scholar
  19. 19.
    Caldas AE, Gray RW, Lemann J Jr: The simultaneous measurement of vitamin D metabolites in plasma: studies in healthy adults and in patients with calcium nephrolithiasis, J Lab Clin Med 91:840, 1978.PubMedGoogle Scholar
  20. 20.
    Taylor CM, Mawer EB, Wallace JE, St. John J, Cochran M, Russell, RGG, Kanis JA: The absence of 24,25-dihydroxycholecalciferol in anephric patients. Clin Sei Mol Med 55:541, 1978.Google Scholar
  21. 21.
    Tanaka Y, Shepard RM, DeLuca HF: The 26-hydroxylation of 25-hydroxyvitamin D3 in vitro by chick renal homogenates. Biochem Biophys Res Commun 83:7, 1978.PubMedCrossRefGoogle Scholar
  22. 22.
    Horst RL: 25-OH-D3-26,23-lactone: a metabolite of vitamin D3 that is 5 times more potent than 25-OH-D3 in the rat plasma competitive protein binding assay. Biochem Biophys Res Commun 89:286, 1979.PubMedCrossRefGoogle Scholar
  23. 23.
    Holick MF, Kleiner-Bossaler A, Schnoes HK, Kasten PM, Boyle IT, DeLuca, HF: 1,24,25-trihydroxyvitamin D3. A metabolite of vitamin D3 effective on intestine. J Biol Chem 248:6691, 1973.PubMedGoogle Scholar
  24. 24.
    DeLuca HF, Schnoes HK. Recent developments in the metabolism of vitamin D, in Norman AW, Schaefer K, von Herrath D, Grigoleit H-G, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds): Vitamin D. Basic Research and Its Clinical Application. Proc. IVth Vitamin D Workshop, Berlin, Walter deGruyter, 1979, p 445.Google Scholar
  25. 25.
    Cundy T, Kanis JA, Paton S, Smith R, Warner GT, Bartlett M, Russell RGG. The biological effects of 1,24,25-trihydroxyvitamin D3 in man. Metab Bone Dis Rei Res 1:293, 1979.Google Scholar
  26. 26.
    Holick MF, Garabedian M, DeLuca, HF: 1,25-Dihydroxycholecalciferol. A metabolite of vitamin D3 active on bone in anephric rats. Science 176:1146, 1972.PubMedCrossRefGoogle Scholar
  27. 27.
    Trummel CL, Raisz LG, Blunt JW, DeLuca HF: 25-Hydroxycholecalciferol: Stimulation of bone resorption in tissue culture. Science 163:1450, 1969.PubMedCrossRefGoogle Scholar
  28. 28.
    Puschett JB, Moranz J, Kurnick WS: Evidence for a direct action of cholecalciferol and 25-hydroxycholecalciferol on the renal transport of phosphate, sodium and calcium. J Clin Invest 51:373, 1972.PubMedCrossRefGoogle Scholar
  29. 29.
    Popovtzer MM, Robinette JB, DeLuca HF, Holick MF. The acute effect of 25-hydroxycholecalciferol on renal handling of phosphorus. Evidence for a parathyroid hormone-dependent mechanism. J Clin Invest 53:913, 1974.PubMedCrossRefGoogle Scholar
  30. 30.
    Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC. The role of 1α,25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59:756, 1977.PubMedCrossRefGoogle Scholar
  31. 31.
    Wilz DR, Gray RW, Dominguez JH, Lemann J Jr: Plasma 1,25-(OH)2-vitamin D concentrations and net intestinal calcium, phosphate and magnesium absorption in humans. Am J Clin Nutr 32:2052, 1979.PubMedGoogle Scholar
  32. 32.
    Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF: Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J Clin Invest 64:729, 1979.PubMedCrossRefGoogle Scholar
  33. 33.
    Brickman AS, Hartenbower DL, Norman AW, Coburn, JW: Actions of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in men. I. Effects on net absorption of phosphorus. Am J Clin Nutr 30:1064, 1977.PubMedGoogle Scholar
  34. 34.
    Raisz LG, Trummel CL, Holick MF, DeLuca HF: 1,25-Dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science 175:768, 1972.PubMedCrossRefGoogle Scholar
  35. 35.
    Hugi K, Bonjour J-P, Fleisch H: Renal handling of calcium: Influence of parathyroid hormone and 1,25-dihydroxyvitamin D3. Am J Physiol 236:F349, 1979.PubMedGoogle Scholar
  36. 36.
    Bonjour J-P, Preston C, Fleisch H: Effect of 1,25-dihydroxy-vitamin D on the renal handling of Pi in thyroparathyroidectomized rats. J Clin Invest 60:1419, 1977.PubMedCrossRefGoogle Scholar
  37. 37.
    Kanis JA, Cundy T, Bartlett M, Smith R, Heynen G, Warner GT, Russell RGG: Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man? Br Med J 1:1382, 1978.PubMedCrossRefGoogle Scholar
  38. 38.
    Haddad JG, Chyu KJ: Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J Clin Endocrinol Metab 33:992, 1971.PubMedCrossRefGoogle Scholar
  39. 39.
    Brumbaugh PF, Haussler HD, Bursac KM, Haussler MR. Filter assay for 1α25-dihydroxy-vitamin D3. Utilization of the hormone’s target tissue chromatin receptor. Biochemistry 13:4091, 1974.PubMedCrossRefGoogle Scholar
  40. 40.
    Eisman JA, Hamstra AF, Kream BE, DeLuca HF. 1,25-Dihydroxy-vitamin D in biological fluids: a simplified and sensitive assay. Science 193:1031, 1976.CrossRefGoogle Scholar
  41. 41.
    Lambert PW, Syverson BF, Arnaud CD, Spelbery TC: Isolation and quantitation of endogenous vitamin D and its physiologically important metabolite in human plasma by high pressure liquid chromatography. J Steroid Biochem 8:929, 1977.PubMedCrossRefGoogle Scholar
  42. 42.
    Avioli LV, Birge S, Lee SW, Slatopolsky E. The metabolic fate of vitamin D3-3H in chronic renal failure. J Clin Invest 47:2239, 1968.PubMedCrossRefGoogle Scholar
  43. 43.
    Gray RW, Weber HP, Dominguez JH, Lemann, J Jr: The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans. J Clin Endocrinol Metab 39:1045, 1974.PubMedCrossRefGoogle Scholar
  44. 44.
    Haddad JG, Rojanasathit S: Acute administration of 25-hydroxycholecalciferol in man. J Clin Endocrinol Metab 42:284, 1976.PubMedCrossRefGoogle Scholar
  45. 45.
    Gray RW, Caldas AE, Wilz DR, Lemann J Jr, Smith GA, DeLuca HF: Metabolism and excretion of 3H-1,25-(OH)2-vitamin D3 in healthy adults. J Clin Endocrinol Metab 46:756, 1978.PubMedCrossRefGoogle Scholar
  46. 46.
    Bell NH, Schaefer PC, Goldsmith R: Effects of pharmacologic doses of 1,25-dihydroxyvitamin D3 on serum calcium, parathyroid hormone and 1,25-dihydroxyvitamin D3 in man. American Society for Bone and Mineral Research, 1979, p. 29A.Google Scholar
  47. 47.
    Avioli LV, Teitelbaum SL: Renal osteodystrophy, in Earley LE, Gottschalk CW (eds): Strauss and Welt’s Diseases of the Kidney, Volume 1. Boston, Little, Brown 1979, Chapter 9, p 307.Google Scholar
  48. 48.
    Liu SH, Chu HI: Studies of calcium and phosphorus metabolism with special reference to pathogenesis and effects of dihydrotachysterol (A.T.10) and iron. Medicine 22:103, 1943.CrossRefGoogle Scholar
  49. 49.
    Stanbury SW, Lumb GA: Metabolic studies of renal osteodystrophy. I. Calcium, phosphorus and nitrogen metabolism in rickets, osteomalacia and hyperparathyroidism complicating chronic uremia and in the osteomalacia of the adult Fanconi syndrome. Medicine 41:1, 1962.PubMedCrossRefGoogle Scholar
  50. 50.
    Coburn JW, Koppel MH, Brickman AS, Massry SG: Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 3:264, 1973.PubMedCrossRefGoogle Scholar
  51. 51.
    Chu HI, Liu SH, Hsu HC, Chuo HC, Cheu SH: Calcium, phosphorus, nitrogen and magnesium metabolism in normal young Chinese adults. Chinese Med J 59:1, 1941.Google Scholar
  52. 52.
    Poskitt EME, Cale TJ, Lawson DEM. Diet, sunlight and 25-hydroxyvitamin D in healthy children and adults. Br Med J 1:331, 1979.CrossRefGoogle Scholar
  53. 53.
    Stryd RP, Gilbertson TJ, Brunden MN: A seasonal variations study of 25-hydroxyvitamin D3 serum levels in normal humans. J Clin Endocrinol Metab 48:771, 1979.PubMedCrossRefGoogle Scholar
  54. 54.
    Morita R, Dokoh S, Fukunaga M, Yamamoto I, Torizuka K: Effects of sunlight exposure on blood concentration of vitamin D derivatives in healthy Japanese adults, in Norman AW, Schaefer K, von Herrath D, Grigoleit H-G, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds): Vitamin D. Basic Research and Its Clinical Application. Proc. IVth Vitamin D Workshop, Berlin, Walter deGruyter, 1979, p 165.Google Scholar
  55. 55.
    Bayard F, Bec PH, Lounet JP: Measurement of plasma 25-hydroxycholecalciferol in man. Eur J Clin Invest 2:195, 1972.PubMedCrossRefGoogle Scholar
  56. 56.
    Bayard F, Bec PH, Tonthat H, Lounet JP: Plasma 25-hydroxycholecalciferol in chronic renal failure. Eur J Clin Invest 3:447, 1973.PubMedCrossRefGoogle Scholar
  57. 57.
    Offerman G, vonHerrath D, Schaffer K. Serum 25-hydroxycholecalciferol in uremia. Nephron 13:260, 1974.CrossRefGoogle Scholar
  58. 58.
    Litteri J, Roginsky M, Moo F, Scipione R, Ellis K, Cohn S. The relationship between calcified tissue mass and plasma 25-hydroxycholecalciferol in chronic renal failure, in Norman AW, Schaefer K, von Herrath D, Grigoleit H-G, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds): Vitamin D and Problems Related to Uremic Bone Disease, Berlin, Walter deGruyter, 1975, p 303.Google Scholar
  59. 59.
    Cook DB, Pierides AM, Shannon G: Seasonal variations of serum 25-hydroxyvitamin D in patients with chronic renal failure treated by regular haemodialysis. Clin Chem Acta 76:251, 1977.CrossRefGoogle Scholar
  60. 60.
    Pietrek J, Kokot F: Serum 25-hydroxyvitamin D in patients with chronic renal disease. Eur J Clin Invest 7:283, 1977.PubMedCrossRefGoogle Scholar
  61. 61.
    Eastwood JB, Daly A, Carter GD, Alaghband-Zadeh J, DeWardener HE: Plasma 25-hydroxyvitamin D in normal subjects and patients with terminal renal failure on maintenance haemodialysis and after transplantation. Clin Sci 57:473, 1979.PubMedGoogle Scholar
  62. 62.
    Nielsen SP, Sørensen OH, Lund B, Bärenholdt O, Munck O, Pedersen K: Calcium metabolism in patients with chronic non-dialytic renal disease. Calcif Tissue Res 21:202, 1976.PubMedCrossRefGoogle Scholar
  63. 63.
    Goldstein DA, Yoshitaka O, Kurokawa K, Massry SG: Blood levels of 25-hydroxyvitamin D in nephrotic syndrome, studies in 26 patients. Ann Int Med 87:664, 1977.PubMedGoogle Scholar
  64. 64.
    Haddad JG Jr, Walgate J: 25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifiediol-binding proteins. J Biol Chem 251:4803, 1976.PubMedGoogle Scholar
  65. 65.
    Farrington K, Skinner RK, Varghese Z, Morehead JF: Hepatic metabolism of vitamin D in chronic renal failure. Lancet 1:321, 1979.PubMedCrossRefGoogle Scholar
  66. 66.
    Shen FH, Baylink DJ, Sherrard DJ, Shen L, Maloney NA, Wergedal JE: Serum immuno-reactive parathyroid hormone and 25-hydroxy-vitamin D in patients with uremic bone disease. J Clin Endocrinol Metab 40:1009, 1975.PubMedCrossRefGoogle Scholar
  67. 67.
    Haddad JG, Min C, Mendelsohn M, Slatopolsky E, Hahn TJ: Competitive protein-binding radioassay of 24,25-dihydroxyvitamin D in sera from normal and anephric subjects. Arch Biochem Biophys 182:390, 1977.PubMedCrossRefGoogle Scholar
  68. 68.
    Weisman Y, Lum GM, Reiter EO, Gilboa N, Knox GF, Root AW: Serum concentrations of 24,25-(OH)2-D in uremic children: A reflection of renal function. J Pediatr 94:190, 1979.PubMedCrossRefGoogle Scholar
  69. 69.
    Taylor CM: 24,25-Dihydroxyvitamin D in human serum, in Norman AW, Schaefer K, von Herrath D, Grigoleit H-G, Coburn JW, DeLuca HF, Mawer EB, Suda T (eds): Vitamin D. Basic Research and Its Clinical Application. Proc. IVth Vitamin D Workshop, Berlin, Walter deGruyter, 1979, p 197.Google Scholar
  70. 70.
    Slatopolsky E, Gray RW, Adams ND, Lewis J, Hruska K, Martin K, Klahr S, DeLuca HF, Lemann J Jr: Low serum levels of 1,25-(OH)2-D are not responsible for the development of secondary hyperparathyroidism in early renal failure. Kidney Int 14:733, 1978.Google Scholar
  71. 71.
    Portale AA, Booth BE, Tsai HC, Morris RC Jr: Reduced plasma 1,25-(OH)2-D concentrations in children with moderate renal insufficiency. Kidney Int 16:922, 1979.Google Scholar
  72. 72.
    Mulluche HH, Werner E, Ritz E: Intestinal absorption of calcium and whole-body calcium retention in incipient and advanced renal failure. Mineral Electrolyte Metab 1:263, 1978.Google Scholar
  73. 73.
    Brickman AS, Coburn JW, Friedman GR, Okamura WH, Massry SG, Norman AW: Comparison of effects of 1α-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. J Clin Invest 57:1540, 1976.PubMedCrossRefGoogle Scholar
  74. 74.
    Coburn JW, Sherrard DJ, Brickman AS, Wong EGC, Norman AW, Singer FR: A skeletal mineralizing defect in dialysis patients: A syndrome resembling osteomalacia but unrelated to vitamin D, in: Contributions in Nephrology, Volume 18. Berlin, Karger, 1980, p 172.Google Scholar
  75. 75.
    Eastwood JB, DeWardener HE, Gray RW, Lemann J Jr: Normal plasma 1,25-(OH)2-vitamin D concentrations in nutritional osteomalacia. Lancet 1:1377, 1979.PubMedCrossRefGoogle Scholar
  76. 76.
    Eastwood JB, Stamp TCB, Harris E, DeWardener HE: Vitamin D deficiency in the osteomalacia of chronic renal failure. Lancet 2:1209, 1976.PubMedCrossRefGoogle Scholar
  77. 77.
    Nielsen HE, Melson F, Lund B, Sorenson OH, Christiansen, MS: Serum 25-hydroxycho-lecalciferol and renal osteodystrophy. Lancet 1:754, 1977.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Jacob LemannJr.
    • 1
  • Richard W. Gray
    • 1
  • Nancy D. Adams
    • 2
  1. 1.Departments of Medicine and Biochemistry and the Clinical Research CenterMedical College of Wisconsin and Milwaukee County Medical ComplexMilwaukeeUSA
  2. 2.Division of NephrologyUniversity of Connecticut School of MedicineFarmingtonUSA

Personalised recommendations